Humanscape to Build the Finest Blockchain-based Patient Network in Asia
– Direct sharing of symptoms and treatment processes and provision of compensation for the sharing of information. – Expected to release blockchain-based “Humanscape” later this year. SEOUL, South Korea, Aug.…
GC Pharma Reports Q2 2018 Results
-Q2 Performance was In-line with Expectations YONGIN, South Korea, July 31, 2018 /PRNewswire/ — GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today…
“Tianfu Talent Recruitment” Launched by Chengdu Hi-Tech Zone First Starts in the UK
CHENGDU, China, Aug. 1, 2018 /PRNewswire/ — Enterprises from Chengdu, organized by Chengdu Hi-Tech Industrial Development Zone (CDHT), visited three European and American countries to recruit talents. On July 13,…
iCONFiT Club: A community of love and fitness
Step into iCONFiT and all your worries as a fitness noob will go right out the window. There is no pre-conceived notion that an unfit person does not belong there.…
Origin Agritech Further Strengthens its Board of Directors
BEIJING, July 30, 2018 /PRNewswire/ — Origin Agritech Ltd. (NASDAQ: SEED) (“the Company” or “Origin”) an agricultural biotechnology trait and corn seed provider, today announced that Mr. Rong Chen and…
WuXi Biologics Commenced Process Validation in MFG2
Produced 7 batches at 6,000L/12,000L bioreactor scale for three programs, the largest scale cell culture operations in China at 100% success rate in MFG2, the largest biologics manufacturing facility globally…
Direct Relief Launches Facebook Fundraiser for Rohingya Mothers and Children
SANTA BARBARA, California, July 26, 2018 /PRNewswire/ — Direct Relief today launched a Facebook fundraiser to provide medical care to Rohingya mothers and children in the world’s largest refugee camp.…
CStone’s MEK Inhibitor CS3006 Receives IND Approval in China
SUZHOU, China, July 30, 2018 /PRNewswire/ — CStone Pharmaceuticals (CStone) today announced that its IND application for CS3006, a small-molecule inhibitor of mitogen-activated protein kinase (MEK), has been approved by…
iCONFiT: A video preview
Energetic, friendly and caring. iCONFiT ensures you become the best version of yourself through fun and energetic workouts. Read our iCONFiT review here.
Foresee Pharmaceuticals Announces Results from a Phase 1 Clinical Study, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile of FP-045, a Potent ALDH2 Activator
TAIPEI, Taiwan, July 26, 2018 /PRNewswire/ — Foresee Pharmaceuticals Co., Ltd. (6576.TWO) (“Foresee”), announced today that it has successfully completed a Phase 1 multiple ascending dose (MAD) clinical study with…
